Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 20;19(1):210.
doi: 10.1186/s12864-018-4599-8.

A highly adaptive microbiome-based association test for survival traits

Affiliations

A highly adaptive microbiome-based association test for survival traits

Hyunwook Koh et al. BMC Genomics. .

Abstract

Background: There has been increasing interest in discovering microbial taxa that are associated with human health or disease, gathering momentum through the advances in next-generation sequencing technologies. Investigators have also increasingly employed prospective study designs to survey survival (i.e., time-to-event) outcomes, but current item-by-item statistical methods have limitations due to the unknown true association pattern. Here, we propose a new adaptive microbiome-based association test for survival outcomes, namely, optimal microbiome-based survival analysis (OMiSA). OMiSA approximates to the most powerful association test in two domains: 1) microbiome-based survival analysis using linear and non-linear bases of OTUs (MiSALN) which weighs rare, mid-abundant, and abundant OTUs, respectively, and 2) microbiome regression-based kernel association test for survival traits (MiRKAT-S) which incorporates different distance metrics (e.g., unique fraction (UniFrac) distance and Bray-Curtis dissimilarity), respectively.

Results: We illustrate that OMiSA powerfully discovers microbial taxa whether their underlying associated lineages are rare or abundant and phylogenetically related or not. OMiSA is a semi-parametric method based on a variance-component score test and a re-sampling method; hence, it is free from any distributional assumption on the effect of microbial composition and advantageous to robustly control type I error rates. Our extensive simulations demonstrate the highly robust performance of OMiSA. We also present the use of OMiSA with real data applications.

Conclusions: OMiSA is attractive in practice as the true association pattern is unpredictable in advance and, for survival outcomes, no adaptive microbiome-based association test is currently available.

Keywords: Community-level association test; High-dimensional compositional data analysis; Microbial group analysis; Microbiome-based association test; Microbiome-based survival analysis; Phylogenetic tree.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Not applicable. All utilized data sets are publicly and freely available which do not require any ethics approval and consent to participate.

Consent for publication

Not applicable. All utilized data sets are publicly and freely available which do not require any consent for publication.

Competing interests

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
An overview which organizes existing methods (blue letters) and our new methods (red letters). Our major proposed method is OMiSA
Fig. 2
Fig. 2
Power estimates for the individual and adaptive tests. The censoring scheme, Ci ~ Unif(0,10), and the same effect directions, where βj ∈ Λ is a vector of the elements sampled from Unif(0,1) (blue), Unif(0,2) (yellow), or Unif(0,3) (red), for a large sample size (n = 100) were surveyed. KU, K0.5, KW, and KBC, indicates the use of unweighted UniFrac, generalized UniFrac with ϴ = 0.5, weighted UniFrac, and the Bray-Curtis dissimilarity kernels, respectively, for MiRKAT-S [24]. (a 10 most abundant OTUs are associated. b 10 random OTUs are associated. c 10 least abundant OTUs are associated. d OTUs in a chosen cluster are associated)
Fig. 3
Fig. 3
Power estimates for the individual and adaptive tests. The censoring scheme, Ci ~ Unif(0,10), and the mixed effect directions, where βj ∈ Λ is a vector of the elements sampled from Unif(− 1,1) (blue), Unif(− 2,2) (yellow), or Unif(− 3,3) (red), for a large sample size (n = 100) were surveyed. KU, K0.5, KW, and KBC, indicates the use of unweighted UniFrac, generalized UniFrac with ϴ = 0.5, weighted UniFrac, and the Bray-Curtis dissimilarity kernels, respectively, for MiRKAT-S [24]. (a 10 most abundant OTUs are associated. b 10 random OTUs are associated. c 10 least abundant OTUs are associated. d OTUs in a chosen cluster are associated)
Fig. 4
Fig. 4
The circular representations of hierarchical taxonomic tree to organize discovered microbial taxa (red circles) at five different taxonomic levels, phylum, class, order, family, and genus. The software tool, GraPhlAn, was used [34]

References

    1. Human Microbiome Project Consortium A framework for human microbiome research. Nature. 2012;486:215–221. doi: 10.1038/nature11209. - DOI - PMC - PubMed
    1. Cho I, Yamanishi S, Cox L, Methé BA, Zavadil J, Li K, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012;488:621–626. doi: 10.1038/nature11400. - DOI - PMC - PubMed
    1. Cox LM, Yamanish S, Sohn J, Alekseyenko AV, Leung JM, Cho I, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 2013;158:705–721. doi: 10.1016/j.cell.2014.05.052. - DOI - PMC - PubMed
    1. Bokulich NA, Chung J, Battaglia T, Henderson N, Jay M, Li H, et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med. 2016;8:343–382. doi: 10.1126/scitranslmed.aad7121. - DOI - PMC - PubMed
    1. Mahana D, Trent CM, Kurtz ZD, Bokulich NA, Battaglia T, Chung J, et al. Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet. Genome Med. 2016;8:48. doi: 10.1186/s13073-016-0297-9. - DOI - PMC - PubMed

Publication types

Substances